HMOX1 as a potential drug target for upper and lower airway diseases: insights from multi-omics analysis

Abstract Background Oxidative stress is key in inflammatory airway diseases. Heme oxygenase 1 (HMOX1) regulates oxidative stress, but its role in airway diseases needs exploration. Methods Differentially expressed genes (DEGs) between healthy nasal mucosa and chronic rhinosinusitis with nasal polyps...

Full description

Saved in:
Bibliographic Details
Main Authors: Enhao Wang, Shazhou Li, Yang Li, Tao Zhou
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Respiratory Research
Subjects:
Online Access:https://doi.org/10.1186/s12931-025-03124-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571371436113920
author Enhao Wang
Shazhou Li
Yang Li
Tao Zhou
author_facet Enhao Wang
Shazhou Li
Yang Li
Tao Zhou
author_sort Enhao Wang
collection DOAJ
description Abstract Background Oxidative stress is key in inflammatory airway diseases. Heme oxygenase 1 (HMOX1) regulates oxidative stress, but its role in airway diseases needs exploration. Methods Differentially expressed genes (DEGs) between healthy nasal mucosa and chronic rhinosinusitis with nasal polyps (CRSwNP) were identified from Gene Expression Omnibus (GEO). Candidate genes were further screened using Gene Set Enrichment Analysis (GSEA) and Random Forest (RF) algorithms. Causal inference between candidate genes and upper and lower airway diseases (CRSwNP, allergic rhinitis (AR), and asthma (AS)) was conducted using bidirectional two-sample Mendelian randomization (TwoSampleMR) analysis. Single-cell RNA sequencing (scRNA-seq) data were used to determine the cellular localization and intercellular interactions of candidate genes. Molecular docking was used to identify potential therapeutic agents. Results HMOX1 expression was significantly elevated in CRSwNP. TwoSampleMR analysis indicated a negative causal relationship between HMOX1 exposure and the occurrence of upper and lower airway diseases (CRSwNP [(odds ratio (OR)/95% confidence interval (CI): 0.945/(0.893–0.999), P = 0.044], AR [OR/95% CI: 0.997/(0.994–0.999), P = 0.007], and AS [OR/95% CI: 0.935/(0.895–0.977), P = 0.003]). scRNA-seq data revealed HMOX1 localization in M2 macrophages. Molecular docking identified 15 antioxidants, including Acetylcysteine and Quercetin, that can upregulate HMOX1 expression. Conclusion HMOX1 may have a protective role in the pathogenesis of upper and lower airway diseases (CRSwNP, AR, and AS) by modulating oxidative stress. Antioxidants that increase HMOX1 expression could offer new therapeutic avenues for these diseases. Clinical trial Not applicable.
format Article
id doaj-art-51b3b8fbbf444b2ca0c4ef401d80853a
institution Kabale University
issn 1465-993X
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj-art-51b3b8fbbf444b2ca0c4ef401d80853a2025-02-02T12:37:56ZengBMCRespiratory Research1465-993X2025-01-0126111510.1186/s12931-025-03124-wHMOX1 as a potential drug target for upper and lower airway diseases: insights from multi-omics analysisEnhao Wang0Shazhou Li1Yang Li2Tao Zhou3Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Prosthodontics, Peking University School and Hospital of StomatologyDepartment of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Background Oxidative stress is key in inflammatory airway diseases. Heme oxygenase 1 (HMOX1) regulates oxidative stress, but its role in airway diseases needs exploration. Methods Differentially expressed genes (DEGs) between healthy nasal mucosa and chronic rhinosinusitis with nasal polyps (CRSwNP) were identified from Gene Expression Omnibus (GEO). Candidate genes were further screened using Gene Set Enrichment Analysis (GSEA) and Random Forest (RF) algorithms. Causal inference between candidate genes and upper and lower airway diseases (CRSwNP, allergic rhinitis (AR), and asthma (AS)) was conducted using bidirectional two-sample Mendelian randomization (TwoSampleMR) analysis. Single-cell RNA sequencing (scRNA-seq) data were used to determine the cellular localization and intercellular interactions of candidate genes. Molecular docking was used to identify potential therapeutic agents. Results HMOX1 expression was significantly elevated in CRSwNP. TwoSampleMR analysis indicated a negative causal relationship between HMOX1 exposure and the occurrence of upper and lower airway diseases (CRSwNP [(odds ratio (OR)/95% confidence interval (CI): 0.945/(0.893–0.999), P = 0.044], AR [OR/95% CI: 0.997/(0.994–0.999), P = 0.007], and AS [OR/95% CI: 0.935/(0.895–0.977), P = 0.003]). scRNA-seq data revealed HMOX1 localization in M2 macrophages. Molecular docking identified 15 antioxidants, including Acetylcysteine and Quercetin, that can upregulate HMOX1 expression. Conclusion HMOX1 may have a protective role in the pathogenesis of upper and lower airway diseases (CRSwNP, AR, and AS) by modulating oxidative stress. Antioxidants that increase HMOX1 expression could offer new therapeutic avenues for these diseases. Clinical trial Not applicable.https://doi.org/10.1186/s12931-025-03124-wHMOX1Chronic rhinosinusitis with nasal polypsAllergic rhinitisAsthmaUpper and lower airway diseases
spellingShingle Enhao Wang
Shazhou Li
Yang Li
Tao Zhou
HMOX1 as a potential drug target for upper and lower airway diseases: insights from multi-omics analysis
Respiratory Research
HMOX1
Chronic rhinosinusitis with nasal polyps
Allergic rhinitis
Asthma
Upper and lower airway diseases
title HMOX1 as a potential drug target for upper and lower airway diseases: insights from multi-omics analysis
title_full HMOX1 as a potential drug target for upper and lower airway diseases: insights from multi-omics analysis
title_fullStr HMOX1 as a potential drug target for upper and lower airway diseases: insights from multi-omics analysis
title_full_unstemmed HMOX1 as a potential drug target for upper and lower airway diseases: insights from multi-omics analysis
title_short HMOX1 as a potential drug target for upper and lower airway diseases: insights from multi-omics analysis
title_sort hmox1 as a potential drug target for upper and lower airway diseases insights from multi omics analysis
topic HMOX1
Chronic rhinosinusitis with nasal polyps
Allergic rhinitis
Asthma
Upper and lower airway diseases
url https://doi.org/10.1186/s12931-025-03124-w
work_keys_str_mv AT enhaowang hmox1asapotentialdrugtargetforupperandlowerairwaydiseasesinsightsfrommultiomicsanalysis
AT shazhouli hmox1asapotentialdrugtargetforupperandlowerairwaydiseasesinsightsfrommultiomicsanalysis
AT yangli hmox1asapotentialdrugtargetforupperandlowerairwaydiseasesinsightsfrommultiomicsanalysis
AT taozhou hmox1asapotentialdrugtargetforupperandlowerairwaydiseasesinsightsfrommultiomicsanalysis